These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 5903172)
1. Relationship of phthalanilide-lipid complexes to uptake and retention of 2-chloro-4',4"-di(2-imidazolin-2-yl)terephthalanilide (NSC 60339) by sensitive and resistant P388 leukemia cells. Yesair DW; Kohner FA; Rogers WI; Baronowsky PE; Kensler CJ Cancer Res; 1966 Feb; 26(2):202-7. PubMed ID: 5903172 [No Abstract] [Full Text] [Related]
2. Relationship of uptake and binding of an antileukemic phthalanilide to its biochemical and chemotherapeutic effects on P388 lymphocytic leukemia cells. Yesair DW; Rogers WI; Baronowsky PE; Wodinsky I; Thayer PS; Kensler CJ Cancer Res; 1967 Feb; 27(2):314-21. PubMed ID: 6018563 [No Abstract] [Full Text] [Related]
3. DISTRIBUTION AND EFFECTS OF 4', 4"-DI(2-IMIDAZOLIN-2-YL)TEREPHTHALANILIDE DIHYDROCHLORIDE HEMIHYDRATE AND ITS 2-CHLORO ANALOGUE IN LYMPHOCYTIC LEUKEMIAS L1210 AND P388. SIVAK A; ROGERS WI; WODINSKY I; KENSLER CJ J Natl Cancer Inst; 1964 Sep; 33():457-65. PubMed ID: 14207856 [No Abstract] [Full Text] [Related]
4. Studies on the intracellular localization and effects of 2-chloro-4',+"-di(2-imidazolin-2-yl)terephthalanilide on mitochondria from P388 lymphocytic leukemia and rat liver. Sivak A; Mahoney AJ; Rogers WI Biochem Pharmacol; 1967 Oct; 16(10):1919-31. PubMed ID: 6065957 [No Abstract] [Full Text] [Related]
5. The antimitochondrial action of 2-choloro-4', 4"-bis(2-imidazolin-2-yl)terephthalanilide and methylglyoxal bis(guanylhydrazone). Pine MJ; DiPaolo JA Cancer Res; 1966 Jan; 26(1):18-25. PubMed ID: 5901744 [No Abstract] [Full Text] [Related]
6. The retention or efflux of phthalanilide (NSC 60339)-lipid complexes by sensitive or resistant murine tumor cells and Escherichia coli B. Yesair DW; HOFook C Cancer Res; 1968 Feb; 28(2):314-9. PubMed ID: 4868016 [No Abstract] [Full Text] [Related]
7. Toxicity and physiologic disposition of 2-amino-4',4"-bis(5-methyl-2-imidazolin-2-yl)terephthalanilide (NSC-66761). Philips FS; Sternberg SS; Cronin AP; Vidal PM Cancer Chemother Rep; 1966; 50(1):9-23. PubMed ID: 4956044 [No Abstract] [Full Text] [Related]
8. SEARCH FOR METABOLITES OF ANTILEUKEMIC PHTHALANILIDES, 2-CHLORO-4',4"-DI-2-IMIDAZOLIN-2-YLTEREPHTHALANILIDE (NSC-60339) AND 2-AMINO-4',-4"-DI-2-IMIDAZOLIN-2-YLTEREPHTHALANILIDE DIHYDROCHLORIDE (NSC-50469). BOOTH J; BOYLAND E; GELLHORN A Cancer Chemother Rep; 1964 Dec; 43():11-8. PubMed ID: 14250645 [No Abstract] [Full Text] [Related]
9. Studies on the formation of phthalanilide-deoxyribonucleic acid complexes and their relationship to chemotherapeutic activity. Sivak A; Rogers WI; Wodinsky I; Kensler CJ Cancer Res; 1965 Jul; 25(6):902-7. PubMed ID: 5891011 [No Abstract] [Full Text] [Related]
10. Anti-cancer activity of the extracts of Rubia cordifolia Linn. (NSC b668893). Adwankar MK; Chitnis MP; Khandalekar DD; Bhadsavale CG Indian J Exp Biol; 1980 Jan; 18(1):102. PubMed ID: 7399571 [No Abstract] [Full Text] [Related]
11. Intracellular adriamycin levels and cytotoxicity in adriamycin-sensitive and adriamycin-resistant P388 mouse leukemia cells. Ganapathi R; Reiter W; Krishan A J Natl Cancer Inst; 1982 Jun; 68(6):1027-32. PubMed ID: 6953267 [TBL] [Abstract][Full Text] [Related]
12. Therapeutic trials and clinical pharmacologic studies of the new terephthalanilide derivative, 2-amino-4,'4"-bis(4-methyl-2-imidazolin-2-yl)-terephthalanilide (AMIT) (NSC 66761). Van Dyk J; Kreis W; Krakoff IH; Tan CT; Cevik N; Burchenal JH Cancer Res; 1968 Aug; 28(8):1566-72. PubMed ID: 5692134 [No Abstract] [Full Text] [Related]
13. In vitro and in vivo studies of the antileukemic action of n,n'-bos [p-(n'-methylamidino)phenyl]terephthalamidine, tetrahydrochloride (NSC 57155) on P815 leukemic cells. Winkler A; Kreis W; Gregg VC; Purple JR; Burchenal JH Cancer Res; 1966 Jul; 26(7):1502-7. PubMed ID: 5916484 [No Abstract] [Full Text] [Related]
14. THE EFFECT OF A PHTHALANILIDE DERIVATIVE ON LIPIDE METABOLISM IN L1210 LEUKEMIA CELLS. GELLHORN A; WAGNER M; RECHLER M; KOREN Z; BENJAMIN W Cancer Res; 1964 Apr; 24():400-8. PubMed ID: 14147813 [No Abstract] [Full Text] [Related]
15. LACK OF CROSS RESISTANCE TO THE AMIDINO AND THE UREIDO DERIVATIVES IN MOUSE LEUKEMIAS MADE RESISTANT TO 4',4"-BIS(2-IMIDAZOLIN-2-YL)-2-CHLOROTEREPHTHALANILIDE DIHYDROCHLORIDE (NSC 38280). BURCHENAL JH; LYMAN MS Proc Can Cancer Conf; 1963; 5():439-48. PubMed ID: 14278873 [No Abstract] [Full Text] [Related]
16. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice. Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799 [TBL] [Abstract][Full Text] [Related]
17. PREVENTION OF ANTILEUKEMIC EFFECT OF TEREPHTHALANILIDE DERIVATIVES IN TRANSPLANTED MOUSE LEUKEMIA P815 BY 4,4'-(TEREPHTHALOYLDIIMINO)DIBENZENESULFONIC ACID DISODIUM SALT (NSC-55156). BURCHENAL JH; PURPLE JR; SPOONER EB; BERCHTOLD R; HIRT R; FISCHER R; BALSIGER R Cancer Chemother Rep; 1964 Dec; 43():5-10. PubMed ID: 14250654 [No Abstract] [Full Text] [Related]
18. STUDIES ON THE MECHANISMS OF ACTION OF VARIOUS PHTHALANILIDE DERIVATIVES BY CROSS-RESISTANCE AND TISSUE CULTURE. BURCHENAL JH; COLEY V; PURPLE JR; BUCHOLZ E; LYMAN MS; KREIS W Cancer Res; 1963 Sep; 23():1364-74. PubMed ID: 14070390 [No Abstract] [Full Text] [Related]
19. Drug resistance studies on intraspecific hybridomas. Pályi I; Turi G; Szikla K; Dallmann L Arch Geschwulstforsch; 1981; 51(1):119-24. PubMed ID: 7259434 [TBL] [Abstract][Full Text] [Related]
20. Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine. Ganapathi R; Grabowski D Cancer Res; 1983 Aug; 43(8):3696-9. PubMed ID: 6861140 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]